Medications as asthma triggers.

[1]  D. Duffy,et al.  Characterization of two polymorphisms in the leukotriene C4 synthase gene in an Australian population of subjects with mild, moderate, and severe asthma. , 2004, The Journal of allergy and clinical immunology.

[2]  P. Kuna,et al.  Aspirin intolerance and allergy to house dust mites: important factors associated with development of severe asthma. , 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[3]  C. Jenkins,et al.  Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice , 2004, BMJ : British Medical Journal.

[4]  A. Higashi,et al.  Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis. , 2004, The Journal of allergy and clinical immunology.

[5]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[6]  D. Shulan,et al.  Use of β-Blockers in Patients with Reactive Airway Disease , 2003 .

[7]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[8]  W. Frishman,et al.  Gender, ethnicity, and genes in cardiovascular disease. Part 2: implications for pharmacotherapy. , 2003, Heart disease.

[9]  S. Dahlén,et al.  Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib. , 2003, The Journal of allergy and clinical immunology.

[10]  S. Woolf,et al.  Treatment of systemic hypertension in patients with pulmonary disease: COPD and asthma. , 2003, Chest.

[11]  R. Simon,et al.  Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. , 2003, The Journal of allergy and clinical immunology.

[12]  R. Simon,et al.  Sensitivity to nonsteroidal anti-inflammatory drugs. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[13]  E. Salpeter,et al.  Cardioselective -Blockers in Patients with Reactive Airway Disease , 2002, Annals of Internal Medicine.

[14]  R. Simon,et al.  The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. , 2002, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[15]  P. Thompson,et al.  The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients , 2002, Thorax.

[16]  Masashi Kobayashi,et al.  Leukotriene C4 synthase promoter polymorphism in Japanese patients with aspirin-induced asthma. , 2002, The Journal of allergy and clinical immunology.

[17]  R. García-Rodríguez,et al.  Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma. , 2002, Chest.

[18]  R. Pauwels,et al.  Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. , 2002, American journal of respiratory and critical care medicine.

[19]  R. Schellenberg,et al.  Anaphylactoid reaction to a cyclooxygenase-2 inhibitor in a patient who had a reaction to a cyclooxygenase-1 inhibitor. , 2001, The New England journal of medicine.

[20]  A. Capriles-Hulett,et al.  Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[21]  B. Dahlén,et al.  Oral and inhalation provocation tests for the diagnosis of
aspirin‐induced asthma , 2001, Allergy.

[22]  D. Stevenson,et al.  Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[23]  R. Simon,et al.  Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. , 2001, The Journal of allergy and clinical immunology.

[24]  J. Murray,et al.  Celecoxib in patients with asthma and aspirin intolerance. The Celecoxib in Aspirin-Intolerant Asthma Study Group. , 2001, The New England journal of medicine.

[25]  M. Cazzola,et al.  Comparison of the effects of single oral doses of nebivolol and celiprolol on airways in patients with mild asthma. , 2000, Chest.

[26]  R. Piepho.  Role of angiotensin-converting-enzyme inhibition in contemporary cardiovascular therapy , 2000 .

[27]  W. Hosemann,et al.  Surgical treatment of nasal polyposis in patients with aspirin intolerance , 2000, Thorax.

[28]  A. Szczeklik,et al.  Natural history of aspirin‐induced asthma , 2000 .

[29]  R. Pauwels,et al.  Indirect bronchial hyperresponsiveness in asthma: mechanisms, pharmacology and implications for clinical research. , 2000, The European respiratory journal.

[30]  J. Drazen,et al.  5' flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States. , 2000, The Journal of allergy and clinical immunology.

[31]  M. Boskabady,et al.  Bronchial responsiveness to beta‐adrenergic stimulation and enhanced beta‐blockade in asthma , 2000, Respirology.

[32]  A. Szczeklik,et al.  Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. , 2000, The European respiratory journal.

[33]  D. Stevenson.  Approach to the patient with a history of adverse reactions to aspirin or NSAIDs: diagnosis and treatment. , 2000, Allergy and asthma proceedings.

[34]  M. Fujimura,et al.  Effect of leukotriene and thromboxane antagonist on propranolol-induced bronchoconstriction. , 1999, American journal of respiratory and critical care medicine.

[35]  J S Alpert,et al.  1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) , 1999, Circulation.

[36]  A. Weinacker,et al.  β‐Adrenergic‐Blocking Agents in Bronchospastic Diseases: A Therapeutic Dilemma , 1999, Pharmacotherapy.

[37]  M. Košnik,et al.  Relative safety of meloxicam in NSAID‐intolerant patients , 1998, Allergy.

[38]  Petkova,et al.  The COX‐1/COX‐2 balance in asthma , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[39]  S. Gottlieb,et al.  Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. , 1998, The New England journal of medicine.

[40]  H. Krumholz,et al.  National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. , 1998, JAMA.

[41]  D. Vaughan,et al.  Angiotensin-converting enzyme inhibitors. , 1998, Circulation.

[42]  L. Dubé,et al.  Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. , 1998, American journal of respiratory and critical care medicine.

[43]  M. Munakata,et al.  Molecular studies of bronchial asthma, sarcoidosis and angiotensin converting enzyme inhibitor‐induced cough , 1998, Respirology.

[44]  S. Holgate,et al.  Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. , 1998, The Journal of clinical investigation.

[45]  G. Emilien,et al.  Current therapeutic uses and potential of β-adrenoceptor agonists and antagonists , 1998, European Journal of Clinical Pharmacology.

[46]  M. Sanak,et al.  Leukotriene C 4 synthase promoter polymorphism and risk of aspirin-induced asthma , 1997, The Lancet.

[47]  M. Kendall.  Clinical relevance of pharmacokinetic differences between beta blockers. , 1997, The American journal of cardiology.

[48]  J. Oates,et al.  Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. , 1996, American journal of respiratory and critical care medicine.

[49]  R. Simon,et al.  Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: long-term outcomes. , 1996, The Journal of allergy and clinical immunology.

[50]  T. Craig.  Drugs to be used with caution in patients with asthma. , 1996, American family physician.

[51]  K. Austen,et al.  Molecular cloning of the gene for human leukotriene C4 synthase. Organization, nucleotide sequence, and chromosomal localization to 5q35. , 1996, The Journal of biological chemistry.

[52]  R. Simon,et al.  Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects. , 1995, The Journal of allergy and clinical immunology.

[53]  D. Stevenson,et al.  Inhibition of monocyte leukotriene B4 production after aspirin desensitization. , 1995, The Journal of allergy and clinical immunology.

[54]  T. Lee,et al.  The effect of aspirin desensitization on urinary leukotriene E4 concentrations in aspirin-sensitive asthma. , 1995, American journal of respiratory and critical care medicine.

[55]  R. Wood.  Bronchospasm and cough as adverse reactions to the ACE inhibitors captopril, enalapril and lisinopril. A controlled retrospective cohort study. , 1995, British journal of clinical pharmacology.

[56]  I. Pavord,et al.  Bronchoprotective role for endogenous prostaglandin E2 , 1995, The Lancet.

[57]  J. Oates,et al.  Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. , 1994, American journal of respiratory and critical care medicine.

[58]  G. Senna,et al.  Tolerability of nimesulide in aspirin-sensitive patients. , 1994, Annals of allergy.

[59]  T. Takishima,et al.  Effect of pilocarpine on propranolol-induced bronchoconstriction in asthma. , 1994, American journal of respiratory and critical care medicine.

[60]  M. Hargreaves.  SODIUM CROMOGLYCATE: A REMEDY FOR ACE INHIBITOR‐INDUCED COUGH , 1993, The British journal of clinical practice.

[61]  T. Peitz.  Long-term prognosis of near-fatal asthma , 1993 .

[62]  K. Sladek,et al.  Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma. , 1993, The European respiratory journal.

[63]  A. Foresi,et al.  Effect of inhaled disodium cromoglycate and nedocromil sodium on propranolol-induced bronchoconstriction. , 1993, Annals of allergy.

[64]  M. Cazzola,et al.  Theophylline in the inhibition of angiotensin-converting enzyme inhibitor-induced cough. , 1993, Respiration; international review of thoracic diseases.

[65]  Alfred O. Berg,et al.  Clinical Guidelines And Primary Care Guidelines For The Diagnosis And Management Of Asthma , 2012 .

[66]  H. Black,et al.  Cough and ACE inhibitors. , 1992, Archives of internal medicine.

[67]  W. Hall,et al.  Cough and Angioneurotic Edema Associated with Angiotensin-Converting Enzyme Inhibitor Therapy , 1992, Annals of Internal Medicine.

[68]  S. Dahlén,et al.  Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics. , 1992, The American review of respiratory disease.

[69]  F. Saulnier,et al.  Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. , 1992, The American review of respiratory disease.

[70]  E. Rosenow,et al.  Asthma-producing drugs. , 1992, Annals of allergy.

[71]  W. Busse,et al.  Angiotensin-converting enzyme inhibitors in patients with bronchial responsiveness and asthma. , 1992, Chest.

[72]  S. Tretli,et al.  Female sex as an important determinant of lisinopril-induced cough , 1992, The Lancet.

[73]  D. Stevenson,et al.  Tryptase and histamine release during aspirin-induced respiratory reactions. , 1991, The Journal of allergy and clinical immunology.

[74]  A. Ford-hutchinson,et al.  Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. , 1991, The American review of respiratory disease.

[75]  M. Young,et al.  Angiotensin-converting enzyme inhibitors and cough. Prevalence in an outpatient medical clinic population. , 1991, Chest.

[76]  D. Stevenson,et al.  Salsalate cross-sensitivity in aspirin-sensitive patients with asthma. , 1990, The Journal of allergy and clinical immunology.

[77]  S. Holgate,et al.  Contribution of histamine and prostanoids to bronchoconstriction provoked by inhaled bradykinin in atopic asthma , 1990, Allergy.

[78]  R. Simon,et al.  Long-term effects of aspirin desensitization--treatment for aspirin-sensitive rhinosinusitis-asthma. , 1990, The Journal of allergy and clinical immunology.

[79]  G. R. Gibson,et al.  Enalapril-induced cough. , 1989, Archives of internal medicine.

[80]  J. Paterson,et al.  Autoradiographic localization of beta-adrenoceptors in asthmatic human lung. , 1989, The American review of respiratory disease.

[81]  P. Ind,et al.  Anticholinergic blockade of beta-blocker-induced bronchoconstriction. , 1989, The American review of respiratory disease.

[82]  P. Just.  The Positive Association of Cough with Angiotensin‐Converting Enzyme Inhibitors , 1989, Pharmacotherapy.

[83]  J. Montserrat,et al.  Aspirin-intolerance as a precipitating factor of life-threatening attacks of asthma requiring mechanical ventilation. , 1989, The European respiratory journal.

[84]  L. Boulet,et al.  Pulmonary function and airway responsiveness during long-term therapy with captopril. , 1989, JAMA.

[85]  J. McEwan,et al.  Angiotensin Converting Enzyme Inhibitors and Cough , 1989, Journal of cardiovascular pharmacology.

[86]  R. Goldszer,et al.  Prevalence of cough during angiotensin-converting enzyme inhibitor therapy. , 1988, American Journal of Medicine.

[87]  A. Mistretta,et al.  Effect of vasoactive intestinal peptide (VIP) on propranolol-induced bronchoconstriction. , 1988, The Journal of allergy and clinical immunology.

[88]  N. Choudry,et al.  Increased cough reflex associated with angiotensin converting enzyme inhibitor cough. , 1987, British medical journal.

[89]  V. Popa.  Captopril-related (and -induced?) asthma. , 1987, The American review of respiratory disease.

[90]  A new method of inhalation challenge with propranolol: comparison with methacholine-induced bronchoconstriction and role of vagal nerve activity. , 1987, The Journal of allergy and clinical immunology.

[91]  L. Gilchrist,et al.  SULINDAC AND COUGH INDUCED BY CONVERTING ENZYME INHIBITORS , 1987, The Lancet.

[92]  P. Barnes,et al.  The effect of an angiotensin converting enzyme inhibitor, ramipril, on bronchial responses to inhaled histamine and bradykinin in asthmatic subjects. , 1987, British journal of clinical pharmacology.

[93]  P. Barnes.  Neural control of human airways in health and disease. , 2015, The American review of respiratory disease.

[94]  W. Stigelman,et al.  Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .

[95]  M. Iseman,et al.  The effect of topical ophthalmic instillation of timolol and betaxolol on lung function in asthmatic subjects. , 1986, The American review of respiratory disease.

[96]  Semple Pf,et al.  Cough and wheeze caused by inhibitors of angiotensin-converting enzyme. , 1986 .

[97]  P. Ind,et al.  Plasma histamine concentration during propranolol induced bronchoconstriction. , 1985, Thorax.

[98]  P. Barnes,et al.  Autoradiographic visualization of beta-adrenoceptor subtypes in human lung. , 1985, The American review of respiratory disease.

[99]  M. Leider.  Goodman & Gilman's The Pharmacological Basis of Therapeutics , 1985 .

[100]  A. Barker,et al.  Respiratory effects of timolol. , 1984, The New England journal of medicine.

[101]  A. Wood.  Pharmacologic differences between beta blockers. , 1984, American heart journal.

[102]  T. Burks,et al.  Capsaicin: hot new pharmacological tool , 1983 .

[103]  H. Meurs,et al.  Protective Effect of Disodium Cromoglycate on Propranolol Challenge , 1982, Allergy.

[104]  R. Simon,et al.  Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period. , 1982, The Journal of allergy and clinical immunology.

[105]  T. Martin,et al.  Timolol-induced bronchospasm in asthmatic bronchitis. , 1981, JAMA.

[106]  R. Simon,et al.  Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges. , 1980, The Journal of allergy and clinical immunology.

[107]  A. Szczeklik,et al.  Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis. , 1977, The Journal of allergy and clinical immunology.

[108]  J. Vane,et al.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. , 1971, Nature: New biology.

[109]  M. Samter,et al.  Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. , 1968, Annals of internal medicine.

[110]  R. Panzani,et al.  The effect of inhalations of bradykinin on healthy and atopic (asthmatic) children. , 1968, International archives of allergy and applied immunology.

[111]  G. Beall,et al.  Bronchial response to beta-adrenergic blockade. , 1966, The New England journal of medicine.